This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
6848 |
4. Check minimum number of events
Min. number of events
3
|
6848 |
5. Include endpointsNone |
6848 |
6. Filter based on genotype QC (FinnGen only) |
6848 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
L02BA Anti-estrogens
based on the number of shared cases.
Similar with more cases:
- Medicines for HER+ breast cancer
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6848 | 6726 | 122 |
| Unadjusted period prevalence (%) | 2.25 | 2.29 | 0.05 |
| Median age at first event (years) | 55.01 | 54.88 | 62.63 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5824
- Matched controls
- 58229
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
9.8
323.0
962
1150
C50.99
ICD-10 Finland
Breast, unspecified
19.0
323.0
1313
878
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
34.4
323.0
1291
479
L02BG04
ATC
letrozole; oral
18.9
323.0
2515
2250
Z31.5
ICD-10 Finland
Genetic counselling
7.0
323.0
885
1462
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
15.9
323.0
922
681
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
18.2
323.0
658
404
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
16.8
323.0
702
472
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
20.1
323.0
790
452
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
15.6
323.0
643
458
115
Kela drug reimbursment
Breast cancer
830.4
323.0
5698
3006
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
19.4
323.0
740
433
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
27.5
323.0
2636
1702
C50
ICD-10 Finland
Malignant neoplasm of breast
17.6
323.0
1005
681
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
32.8
323.0
3194
2077
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
12.9
323.0
796
707
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
17.5
323.0
628
400
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
29.3
323.0
962
390
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
23.7
323.0
773
374
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
20.2
323.0
1005
596
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
18.1
323.0
1806
1414
A04AD12
ATC
aprepitant; systemic
16.3
323.0
715
494
L03AA13
ATC
pegfilgrastim; parenteral
13.8
323.0
1209
1088
192
Kela drug reimbursment
Fulvestrant
1413.4
323.0
516
*
JN4BD
NOMESCO Finland
Extensive body CT
5.7
323.0
1392
3062
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
26.7
323.0
860
375
A03FA01
ATC
metoclopramide; systemic, rectal
8.6
323.0
3527
8801
TQW20
NOMESCO Finland
Tatoe
27.9
323.0
635
254
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
18.1
323.0
1397
1000
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
9.0
323.0
1240
1690
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.1
323.0
2409
8540
L02BG03
ATC
anastrozole; oral
18.4
323.0
748
462
X76
ICPC
Malignant neoplasm breast female
17.4
323.0
833
554
NK6AN
NOMESCO Finland
Total body bone isotope imaging
16.0
323.0
666
467
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.0
323.0
3639
17142
L02BG06
ATC
exemestane; oral
29.6
323.0
781
303
A04AA55
ATC
palonosetron, combinations; systemic
10.4
323.0
864
956
PJA12
NOMESCO Finland
Sentinel node biopsy
21.4
323.0
3207
3147
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.0
323.0
1013
1090
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
30.9
323.0
2279
1186
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
17.5
323.0
2671
2693
1CD02
NOMESCO Finland
NA
50.3
323.0
502
109
ZX120
NOMESCO Finland
Intravenous
5.2
323.0
1193
2765
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
18.0
323.0
1129
767
A04AA02
ATC
granisetron; systemic, transdermal
13.5
323.0
1678
1699
L02BA01
ATC
tamoxifen; oral
5560.2
323.0
5657
289
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
28.1
323.0
771
315
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
14.9
323.0
1685
1550
HAB40
NOMESCO Finland
Wedge excision of mammary gland
15.5
323.0
2068
1994
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
11.4
323.0
850
857
L02BA03
ATC
fulvestrant; parenteral
672.0
323.0
550
9
H02AB02
ATC
dexamethasone; systemic
16.7
323.0
2946
3358
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
11.5
323.0
725
712
HAC20
NOMESCO Finland
Total mastectomy
25.4
323.0
2266
1424
HA1AA
NOMESCO Finland
X-ray mammography
19.8
323.0
3104
3175
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
14.9
319.8
554
408
1501
Kela drug reimbursment
Palbociclib
57.1
315.2
375
70
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
13.4
314.9
571
467
ZX090
NOMESCO Finland
Other technic of radiotherapy
10.8
304.4
616
632
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.2
304.1
1063
2414
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
10.0
299.1
630
696
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
21.1
296.1
449
230
R4110
NOMESCO Finland
Physiotherapy
3.0
295.7
2303
10333
HAB99
NOMESCO Finland
Other partial excision of mammary gland
8.4
280.3
659
876
394
Kela drug reimbursment
Palbociclib
56.0
274.7
328
62
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
12.0
266.9
510
463
HAE99
NOMESCO Finland
Other reconstruction of breast
22.9
261.3
385
179
A04AA01
ATC
ondansetron; systemic, rectal
5.0
260.8
930
2132
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
259.9
2601
13371
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
258.1
2881
15762
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
9.1
243.3
539
644
L01XE33
ATC
[U] palbociclib; oral
65.3
240.4
280
45
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
6.0
235.4
708
1322
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
14.4
231.4
405
301
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
20.8
225.6
343
175
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
32.5
224.7
300
97
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
16.5
222.6
368
237
M05BX04
ATC
denosumab; parenteral
5.2
221.9
757
1635
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
7.5
219.9
552
802
WF003
NOMESCO Finland
Adjuvant radiotherapy
6.7
210.9
572
927
ZZF00
NOMESCO Finland
Graft of adipose tissue
18.3
210.3
334
193
ZXA05
NOMESCO Finland
Left side
2.6
206.8
2078
10336
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.1
206.2
537
821
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
202.1
1036
3280
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
23.2
198.0
290
131
WF049
NOMESCO Finland
Radiotherapy of metastasis
8.5
192.3
441
553
N63
ICD-10 Finland
Unspecified lump in breast
3.9
188.6
867
2492
L01BC06
ATC
capecitabine; oral
6.8
188.0
505
804
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
17.3
186.6
302
183
ZXA00
NOMESCO Finland
Right side
2.4
184.2
2120
11170
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
25.7
183.8
261
106
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
14.8
183.2
316
225
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
15.3
175.5
298
204
L02AE03
ATC
goserelin; implant
17.1
174.7
284
174
ZZR10
NOMESCO Finland
Flap of skin and muscle
16.3
173.1
287
185
L03AA02
ATC
filgrastim; parenteral
7.8
172.1
419
576
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
28.3
163.6
226
83
ZX112
NOMESCO Finland
Subcutaneous
9.2
162.8
356
410
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
20.6
159.8
243
123
Z3226
NOMESCO Finland
Physiotherapist
2.5
159.4
1488
6908
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
26.6
157.4
221
86
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.2
152.5
313
321
L01CA04
ATC
vinorelbine; systemic
20.2
147.9
226
116
Z3231
NOMESCO Finland
Registered nurse
2.3
147.8
1888
10210
WX702
NOMESCO Finland
Supraglottic ventilation device
4.2
145.5
608
1583
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
24.2
145.5
210
90
N06AX16
ATC
venlafaxine; oral
2.7
145.2
1211
5234
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
26.8
144.2
202
78
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
144.0
2707
17273
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
7.5
143.3
354
495
L01EF01
ATC
palbociclib; oral
39.3
140.4
179
47
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
16.9
139.5
227
139
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
15.0
139.3
238
165
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
27.1
138.9
194
74
HAC25
NOMESCO Finland
Radical mastectomy
25.9
138.7
196
78
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.3
138.4
452
911
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
17.8
138.2
221
129
L02BA02
ATC
toremifene; oral
465.1
137.8
137
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
5.9
136.3
402
717
ZX080
NOMESCO Finland
Image guided radiotherapy
6.7
135.7
364
573
FM1FN
NOMESCO Finland
Heart function isotope examination
19.7
133.8
206
108
L03AA14
ATC
lipegfilgrastim; parenteral
6.7
130.9
350
548
A79
ICPC
Malignancy NOS
11.6
130.6
251
226
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
9.6
128.2
272
296
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
10.5
128.0
258
255
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
17.8
127.1
203
118
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
10.5
120.8
244
242
HAD40
NOMESCO Finland
Mastopexy
19.0
120.7
188
102
M05BA02
ATC
clodronic acid; systemic
35.3
118.9
155
45
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
17.7
118.3
189
110
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
18.5
117.7
185
103
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
29.3
117.2
160
56
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
9.1
117.1
256
293
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
20.5
115.3
175
88
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
12.6
114.7
211
173
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
8.6
112.3
253
305
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
25.1
111.7
159
65
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
12.4
111.6
207
173
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
16.4
111.3
183
115
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
111.1
1788
10408
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
16.2
110.9
183
116
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
12.7
109.3
200
162
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
12.2
108.7
203
172
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
7.6
107.8
264
363
1XC03
NOMESCO Finland
NA
26.6
105.7
148
57
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
21.8
103.0
153
72
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
12.5
102.4
189
156
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
11.9
101.3
191
165
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
9.3
98.0
210
232
HAD99
NOMESCO Finland
Other plastic operation on breast
12.7
95.6
175
142
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
13.0
94.6
171
135
TQB05
NOMESCO Finland
Puncture of skin of trunk
9.3
92.8
199
220
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
91.6
2509
17341
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
5.4
91.6
291
564
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
14.4
89.8
155
110
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
9.5
89.6
190
206
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
88.7
413
1167
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
11.2
87.6
170
156
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
10.6
87.4
174
168
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.8
86.9
391
1073
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
14.5
86.6
149
105
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
15.3
85.6
144
96
B01AB05
ATC
enoxaparin; parenteral
1.8
85.6
1986
12923
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
10.2
85.3
174
176
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.0
83.3
213
312
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
81.5
902
4381
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
80.8
416
1273
L02AE02
ATC
leuprorelin; implant, parenteral
6.6
80.3
214
332
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
14.1
79.8
139
101
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.8
79.4
208
315
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
6.5
79.3
216
345
LCA06
NOMESCO Finland
Biopsy of endometrium
2.0
78.8
1184
6549
Z51.5
ICD-10 Finland
Palliative care
3.3
77.6
418
1323
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
3.8
77.3
350
964
N02BE01
ATC
paracetamol; systemic, rectal
2.1
77.3
5176
46123
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
76.9
653
2766
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.6
74.8
275
624
N02AA05
ATC
oxycodone; systemic
2.1
73.5
911
4637
Z51.0
ICD-10 Finland
Radiotherapy session
7.7
72.5
174
232
N84.0
ICD-10 Finland
Polyp of corpus uteri
2.3
71.7
762
3615
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
10.4
71.6
144
142
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
27.2
71.5
99
37
WZC30
NOMESCO Finland
Teaching
2.2
71.3
867
4372
R50.9
ICD-10 Finland
Fever, unspecified
2.2
70.6
828
4108
PJW99
NOMESCO Finland
Other operation on lymphatic system
10.8
69.5
137
130
A46
ICD-10 Finland
Erysipelas
2.2
69.2
791
3876
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
11.2
67.9
131
119
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
17.8
67.6
107
61
XX1XN
NOMESCO Finland
Other isotope examination
7.0
67.2
171
249
A02BC02
ATC
pantoprazole; systemic
1.6
66.7
3934
32532
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
18.2
66.3
104
58
X21
ICPC
Breast sympt/compl female other
4.4
65.9
252
594
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
18.8
65.8
102
55
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
21.7
64.9
96
45
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
13.7
64.8
114
85
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
13.3
64.7
115
88
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
21.7
62.3
92
43
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
6.4
62.0
168
267
HA1BA
NOMESCO Finland
Extensive X-ray mammography
8.6
61.4
137
163
WF004
NOMESCO Finland
Palliative radiotherapy
6.0
60.7
173
294
HA1HA
NOMESCO Finland
Tomosynthesis mammography
8.6
60.4
135
161
X26
ICPC
Fear of breast cancer female
8.3
60.3
137
168
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.6
59.0
213
474
WX402
NOMESCO Finland
General anaesthesia
1.9
58.9
1043
6057
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
58.9
434
1687
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
8.4
58.7
133
162
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.8
58.2
1283
8011
JN4CD
NOMESCO Finland
Very extensive body CT
3.4
57.3
290
873
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
10.9
57.3
112
105
JN4AD
NOMESCO Finland
Body CT examination
2.5
57.0
480
2009
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
22.1
56.6
83
38
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
15.5
55.9
93
61
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
4.7
55.2
194
420
Z2221
NOMESCO Finland
Medical doctor
1.6
53.8
1658
11370
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.4
53.6
509
2266
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.4
52.9
226
5435
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
11.3
52.7
101
91
3AA13
NOMESCO Finland
NA
22.3
52.7
77
35
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
51.5
450
1921
X19
ICPC
Breast lump/mass female
4.4
51.0
191
441
TQW99
NOMESCO Finland
Other minor procedure on skin
2.8
50.9
342
1252
ZXE00
NOMESCO Finland
One hour or less
1.5
50.0
2293
17283
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
8.4
49.9
112
135
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.3
49.9
91
3220
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
9.2
49.2
105
116
QBJ00
NOMESCO Finland
Liposuction in trunk
8.1
49.1
113
142
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
4.4
48.6
184
430
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
8.0
48.4
112
142
HA1SA
NOMESCO Finland
Expansion mammography
9.3
48.3
102
111
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.7
48.0
217
596
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
11.0
48.0
93
86
M05BA06
ATC
ibandronic acid; systemic
3.5
46.1
224
653
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
13.8
45.4
79
58
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.1
45.1
183
457
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.6
44.9
134
242
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5.0
44.6
149
306
HAF00
NOMESCO Finland
Excision of local recurrence of breast cancer
35.9
44.4
57
16
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
43.6
657
3565
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
2.3
43.4
447
2065
HAD20
NOMESCO Finland
Liposuction of breast
19.9
43.0
65
33
J01MA12
ATC
levofloxacin; systemic
1.7
42.6
969
6035
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
18.0
40.9
64
36
QBA00
NOMESCO Finland
Puncture of skin of trunk
11.1
40.7
78
71
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
4.1
40.3
163
406
9703
FHL
Breast resection
5.0
40.2
134
275
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.3
40.0
211
656
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
9.2
40.0
85
94
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.7
39.9
2708
32397
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
6.4
39.6
106
167
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.6
39.6
87
102
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
8.8
39.5
86
99
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
38.0
316
1310
N62
ICD-10 Finland
Hypertrophy of breast
2.4
37.4
336
1451
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
36.8
5140
47648
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.5
36.8
135
307
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
13.1
36.8
65
50
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
13.5
36.6
64
48
N64.9
ICD-10 Finland
Disorder of breast, unspecified
4.6
36.5
130
287
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
36.3
527
2811
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
4.6
36.2
129
285
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
13.9
36.0
62
45
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
18.8
35.2
54
29
B01AB10
ATC
tinzaparin; parenteral
2.1
35.0
443
2237
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
12.8
34.7
62
49
J01DB01
ATC
cefalexin; oral
1.5
34.6
4558
41179
HAA10
NOMESCO Finland
Biopsy of mammary gland
5.0
34.5
114
233
5BX04
NOMESCO Finland
NA
57.5
34.2
40
7
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
3.6
33.9
159
452
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
12.3
33.6
61
50
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.5
33.5
161
467
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
12.1
33.3
61
51
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
33.1
344
1593
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
32.7
350
1644
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
14.6
32.7
55
38
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.1
32.3
188
628
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
32.2
1928
14964
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.2
32.2
333
1538
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
13.4
32.1
56
42
N05CF01
ATC
zopiclone; oral
1.4
31.6
1862
14397
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
5.3
31.3
98
189
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
3.7
31.2
141
389
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
12.5
31.2
56
45
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.1
31.0
125
312
B29
ICPC
Lymph/immune mech sympt/complt other
9.8
31.0
63
65
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
8.8
30.5
66
76
A14AB01
ATC
nandrolone; parenteral
15.6
29.4
48
31
HAD00
NOMESCO Finland
Augmentation mammoplasty
18.1
29.1
45
25
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
7.1
29.0
72
103
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.0
28.8
172
585
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
11.9
28.3
52
44
ULC02
NOMESCO Finland
Hysteroscopy
1.9
28.3
442
2415
5BA08
NOMESCO Finland
NA
7.8
28.1
65
84
ZZS55
NOMESCO Finland
Distension of tissue expander
39.1
28.0
35
9
ZXD20
NOMESCO Finland
Day surgery
1.6
27.9
776
5057
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
10.3
27.4
54
53
LCB98
NOMESCO Finland
Other transluminal endoscopic excision of lesion of uterus
4.2
27.3
107
261
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.4
27.2
136
408
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
23.9
26.9
38
16
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
23.9
26.9
38
16
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
4.6
26.7
94
207
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
26.5
420
2307
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
9.9
26.4
53
54
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
17.5
25.7
40
23
1741A
ICD-9 Finland
Malignant neoplasm of female breast, Central portion
24.1
25.6
36
15
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
4.3
25.5
96
226
ZSZ10
NOMESCO Finland
Secondary repair operation
14.6
25.1
42
29
3030
Kela drug reimbursment
Abemaciclib
70.2
24.8
28
*
1515
Kela drug reimbursment
NA
70.2
24.8
28
*
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
21.3
24.7
36
17
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
24.7
342
1789
J01CE08
ATC
benzathine benzylpenicillin; parenteral
4.8
24.6
83
175
A04AA03
ATC
tropisetron; systemic
7.7
24.2
56
73
Z2446
NOMESCO Finland
Social worker
2.0
24.0
322
1664
9706
FHL
Ablation mammae, includes axillary exploration
8.3
23.5
52
63
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
7.2
23.4
57
80
D24
ICD-10 Finland
Benign neoplasm of breast
2.5
22.9
179
719
N05CB02
ATC
barbiturates in combination with other drugs
2.3
22.8
214
945
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
30.1
22.7
30
10
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
8.3
22.5
50
61
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
4.4
22.4
81
184
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
12.7
22.0
39
31
L01EF03
ATC
abemaciclib; oral
62.7
21.8
25
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
6.2
21.3
57
92
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
21.2
296
1550
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.3
21.2
209
945
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
4.9
20.9
68
139
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
20.7
990
7254
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
20.5
796
5588
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.6
20.4
93
261
Z31.6
ICD-10 Finland
General counselling and advice on procreation
7.6
20.3
47
62
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.8
20.2
86
228
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
10.9
20.1
38
35
J94.8
ICD-10 Finland
Other specified pleural conditions
3.6
20.0
91
255
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
5.5
19.8
59
109
1DB03
NOMESCO Finland
NA
35.8
19.8
25
7
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
4.1
19.6
77
190
WW500
NOMESCO Finland
Blood transfusion
2.2
19.5
201
930
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
19.4
460
2863
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.7
19.2
65
139
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
6.3
19.2
51
82
C507
ICD-10 Finland
NA
46.1
19.2
23
5
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
6.1
19.1
52
86
HA1DA
NOMESCO Finland
Restricted mammography
8.6
19.1
41
48
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
19.0
324
1824
THA00
NOMESCO Finland
Needle biopsy of mamilla
8.1
18.9
42
52
8522/3-C50.4
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast
11.8
18.7
34
29
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.9
18.6
265
1398
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
7.4
18.6
44
60
JN5AN
NOMESCO Finland
Total body isotope imaging
18.7
18.6
28
15
C10AA01
ATC
simvastatin; oral
0.8
18.4
1372
16890
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
8.4
18.4
40
48
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
16.2
18.3
29
18
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.5
18.1
654
4517
8524/3-C50.4
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast
52.6
17.9
21
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.6
17.8
81
228
C10AA05
ATC
atorvastatin; oral
0.7
17.7
1150
14443
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.1
17.7
192
910
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
9.3
17.6
36
39
SPAT1269
SPAT
Other puncture and/or drainage
4.6
17.5
61
135
1748X
ICD-9 Finland
Malignant neoplasm of female breast, Other specified sites of female breast
11.5
17.5
32
28
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
5.5
17.4
51
93
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.7
17.4
59
127
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
16.9
17.3
27
16
1CD01
NOMESCO Finland
NA
9.0
17.3
36
40
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.6
17.2
124
480
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.7
17.1
118
443
1XC13
NOMESCO Finland
NA
17.4
16.9
26
15
M05BA04
ATC
alendronic acid; oral
1.5
16.9
539
3617
8523/3-C50.4
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast
19.3
16.8
25
13
QCJ00
NOMESCO Finland
Liposuction in upper limb
15.1
16.6
27
18
WX110
NOMESCO Finland
Local anesthesy
1.3
16.6
3582
32462
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
5.6
16.4
47
84
A21
ICPC
Risk factor for malignancy
10.0
16.4
32
32
OAA41
NOMESCO Finland
Health check based on individual needs
11.2
16.2
30
27
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
2.4
16.1
133
553
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
12.8
16.1
28
22
N85.9
ICD-10 Finland
Noninflammatory disorder of uterus, unspecified
3.7
16.1
70
191
XX1AD
NOMESCO Finland
Other CT-examination
4.5
16.0
56
125
5702
FHL
Local lymph node removal (eg armpit, groin)
5.3
16.0
48
91
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
10.8
15.9
30
28
WX704
NOMESCO Finland
Intubation
1.7
15.9
354
2165
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
15.8
2241
25659
WF002
NOMESCO Finland
Radical radiotherapy
2.2
15.6
151
681
WX400
NOMESCO Finland
Inhalation anesthesy
1.9
15.6
231
1239
8520/3-C50.8
ICD-O-3
Lobular carcinoma, NOS, of overlapping lesion of breast
9.2
15.6
32
35
156
Kela drug reimbursment
Lapatinib
17.2
15.6
24
14
1BC02
NOMESCO Finland
NA
26.3
15.6
21
8
A08
ICPC
Swelling
1.9
15.4
233
1260
NF3AA
NOMESCO Finland
Femur X-ray examination
2.7
15.3
107
406
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
6.7
15.2
38
57
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
13.0
15.1
26
20
L01XE07
ATC
[U] lapatinib; oral
17.7
15.1
23
13
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
4.6
15.1
52
115
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.0
15.0
87
295
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
13.9
15.0
25
18
ZZR00
NOMESCO Finland
Flap of skin
2.4
14.6
118
488
GA5AA
NOMESCO Finland
Rib X-ray examination
5.6
14.6
42
76
L02AB01
ATC
megestrol; oral (progestogens)
80.3
14.6
16
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.1
14.5
170
836
205
Kela drug reimbursment
Chronic hypertension
0.7
14.5
755
9826
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.8
14.5
61
163
JN6AD
NOMESCO Finland
CT of torso and neck
3.2
14.5
75
236
D05.0
ICD-10 Finland
Lobular carcinoma in situ
5.6
14.4
41
73
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
14.4
209
1112
L95
ICPC
Osteoporosis
1.9
14.4
211
1129
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
5.1
14.3
44
86
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
9.7
14.2
28
29
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
14.1
584
4140
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
14.1
374
2397
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
14.1
673
4907
C10AA07
ATC
rosuvastatin; oral
0.7
13.9
707
9246
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
13.8
668
4879
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
23.8
13.8
19
8
C08CA01
ATC
amlodipine; oral
0.8
13.5
1138
13907
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
7.1
13.5
32
45
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
1.7
13.5
280
1682
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
16.2
13.4
21
13
LCA10
NOMESCO Finland
Curettage of body of uterus
1.9
13.4
199
1072
ZX121
NOMESCO Finland
Central venous catheter
6.1
13.1
35
58
J02AC01
ATC
fluconazole; systemic
1.2
13.1
2609
23135
L58.9
ICD-10 Finland
Radiodermatitis, unspecified
28.4
12.9
17
6
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.0
12.9
160
807
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
19.0
12.9
19
10
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
6.4
12.9
33
52
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.6
12.8
253
3917
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.2
12.7
122
549
G03FB08
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
0.6
12.7
198
3235
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.9
12.6
180
956
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.3
12.6
114
502
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
12.5
669
8699
ZXD05
NOMESCO Finland
Urgent procedure
1.3
12.5
1387
11481
N05CF02
ATC
zolpidem; oral
1.3
12.5
974
7689
8140/3-C50.9
ICD-O-3
Adenocarcinoma, NOS, of breast, NOS
10.0
12.4
24
24
TQW40
NOMESCO Finland
Remowal of suture of skin
1.6
12.4
344
2231
8211/3-C50.9
ICD-O-3
Tubular adenocarcinoma of breast, NOS
13.2
12.4
21
16
C50.61
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, ductal tumor
13.2
12.4
21
16
A06AH03
ATC
naloxegol; oral
3.2
12.3
64
203
B01AC04
ATC
clopidogrel; oral
0.6
12.3
252
3869
TJA10
NOMESCO Finland
Laparocentesis
7.1
12.2
29
41
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
12.2
143
704
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.7
12.2
30
45
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
12.1
322
2067
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.6
12.0
53
149
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
11.9
604
7920
X62
ICPC
Female Genital, Administrative procedure
46.7
11.9
14
*
WE200
NOMESCO Finland
Profylactive therapy of malignancy with hormones
46.7
11.9
14
*
HA1AE
SPAT
NA
2.2
11.8
118
542
ZX050
NOMESCO Finland
Stereotactic radiotherapy
4.4
11.8
41
93
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
3.7
11.7
50
137
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
16.4
11.6
18
11
9702
FHL
Breast exploration and possible tumor removal
2.2
11.6
112
507
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.6
11.6
151
2576
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
9.2
11.5
23
25
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.9
11.4
67
231
C50.62
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, lobular tumor
120.2
11.4
12
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
6.0
11.3
30
50
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
5.3
11.3
33
62
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
15.0
11.3
18
12
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
11.2
1167
9564
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
11.2
350
2336
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
3.5
11.2
50
142
SPAT1262
SPAT
Handing over of treatment supplies
0.7
11.2
426
5834
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
5.7
11.1
31
55
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
10.8
431
5866
A10BA02
ATC
metformin; oral
0.8
10.7
737
9273
8524/3-C50.9
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of breast, NOS
21.5
10.7
15
7
R18
ICD-10 Finland
Ascites
2.3
10.6
92
397
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
7.5
10.6
24
32
1XC14
NOMESCO Finland
NA
60.1
10.6
12
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
10.6
311
2048
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.0
10.6
133
677
9719
FHL
Other measure in this category
6.0
10.5
28
47
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
7.0
10.5
25
36
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
10.5
331
2216
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
6.5
10.5
26
40
TPX15
NOMESCO Finland
Removal of vascular injection port
4.3
10.4
37
86
SPAT1310
SPAT
Counselling related to known health issue
0.8
10.4
1096
13123
E66.01
ICD-10 Finland
Obesity due to excess calories
0.6
10.4
159
2608
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
5.6
10.4
29
52
XX9XW
NOMESCO Finland
NA
3.8
10.3
42
111
L01XE10
ATC
[U] everolimus; oral
32.6
10.3
13
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.4
10.3
81
334
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.6
10.2
73
286
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
10.1
765
9515
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.1
10.1
54
177
SPAT1097
SPAT
Recording of ECG
0.7
10.0
384
5262
NK6SN
NOMESCO Finland
Bone SPECT
11.3
10.0
18
16
ZSZ00
NOMESCO Finland
Primary repair operation
8.4
10.0
21
25
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.1
10.0
109
525
A55
ICPC
General and Unspecified, Local injection/infiltration
3.3
10.0
49
151
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
9.9
1921
16835
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
9.8
359
4958
AN1
HP
Coronary angiography
0.6
9.7
176
2778
N02AA01
ATC
morphine; systemic, rectal
3.1
9.7
52
171
T90
ICPC
Diabetes non-insulin dependent
0.8
9.7
590
7551
SPAT1324
SPAT
Screening procedure
0.8
9.7
769
9515
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
4.3
9.7
34
79
158
Kela drug reimbursment
Everolimus
13.4
9.6
16
12
B01AA03
ATC
warfarin; systemic
0.7
9.6
409
5515
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
4.2
9.6
35
84
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.8
9.6
60
216
M54.4
ICD-10 Finland
Lumbago with sciatica
0.7
9.5
515
6697
N06AX11
ATC
mirtazapine; oral
1.2
9.5
1628
14084
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
9.5
546
7043
9710
FHL
Existence of a relapse
30.0
9.4
12
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.5
9.4
86
1606
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
3.9
9.3
36
92
ZX100
NOMESCO Finland
Oral
2.6
9.2
66
257
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
13.7
9.2
15
11
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
7.7
9.1
20
26
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.1
9.1
100
485
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
0.7
9.1
356
4860
S18
ICPC
Laceration/cut
1.2
9.1
1976
17476
X79
ICPC
Benign neoplasm breast female
8.3
9.0
19
23
R87.8
ICD-10 Finland
Abnormal findings in specimens from female genital organs, other abnormal findings
3.4
9.0
42
125
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
5.6
9.0
25
45
WE198
NOMESCO Finland
Palliative cystotatic therapy
10.0
9.0
17
17
N05AD01
ATC
haloperidol; systemic
1.9
9.0
117
607
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.8
8.9
1007
11998
N64.8
ICD-10 Finland
Other specified disorders of breast
3.4
8.9
41
121
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
18.6
8.9
13
7
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
24.0
8.9
12
5
HAA00
NOMESCO Finland
Incision of mammary gland
5.7
8.9
24
42
WW200
SPAT
NA
0.7
8.9
249
3596
Z71.8
ICD-10 Finland
Other specified counselling
1.2
8.8
1084
9036
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.7
8.8
57
212
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.8
8.8
581
7362
XX2ET
NOMESCO Finland
NA
10.7
8.8
16
15
LDA00
NOMESCO Finland
Dilatation of cervix uteri
2.7
8.8
57
213
WF099
NOMESCO Finland
Other radiotherapy
3.4
8.7
40
118
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.7
8.6
461
6006
N05BA06
ATC
lorazepam; systemic, sublingual
1.6
8.6
227
1460
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.8
8.5
845
10209
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
3.7
8.5
35
95
8524/3-C50.2
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-inner quadrant of breast
90.2
8.4
9
*
L71
ICPC
Malignant neoplasm musculoskeletal
12.7
8.4
14
11
Y16
ICPC
Breast symptom/complaint male
12.7
8.4
14
11
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
4.8
8.3
26
54
TLC02
NOMESCO Finland
Simple extraction of IUD
1.6
8.3
235
1537
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.0
8.3
102
516
SPAT1053
SPAT
Memory test
0.7
8.3
343
4641
RD211
NOMESCO Finland
NA
1.6
8.2
206
1307
SPAT1249
SPAT
Treatment-related counselling outside office
0.8
8.2
1492
17002
S76
ICPC
Skin infection other
1.6
8.2
207
1316
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
3.3
8.2
38
114
L09
ICPC
Arm symptom/complaint
1.6
8.2
204
1296
N61
ICD-10 Finland
Inflammatory disorders of breast
1.9
8.2
110
578
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
7.5
8.1
18
24
J01FF01
ATC
clindamycin; systemic
1.2
8.1
1260
10760
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.8
8.1
748
9115
E0000UV
ATC
NA
1.2
8.1
1992
17767
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
3.1
8.1
42
137
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
8.1
8.1
17
21
N05BA04
ATC
oxazepam; oral
1.2
8.1
1261
10776
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
8.0
353
2535
B01AB04
ATC
dalteparin; parenteral
1.6
8.0
224
1462
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
3.3
8.0
38
116
L04AX01
ATC
azathioprine; systemic
0.5
8.0
65
1256
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.6
8.0
55
211
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.6
8.0
106
1794
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.8
8.0
481
6172
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
0.6
8.0
151
2355
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
5.8
8.0
21
36
Z50.1
ICD-10 Finland
Other physical therapy
1.5
7.9
263
1787
J05AB01
ATC
aciclovir; systemic
1.2
7.9
1089
9186
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
2.8
7.9
47
168
ZXA10
NOMESCO Finland
Bilateral
1.2
7.8
904
7471
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
4.0
7.8
29
72
SPAT1301
SPAT
No procedures
0.8
7.8
1103
12875
8480/3-C50.4
ICD-O-3
Mucinous adenocarcinoma of upper-outer quadrant of breast
10.8
7.8
14
13
6117B
ICD-9 Finland
Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]
3.0
7.8
42
141
B04
ICPC
Blood symptom/complaint
3.7
7.7
31
83
3002
Kela drug reimbursment
Ribociclib
45.0
7.7
9
*
1514
Kela drug reimbursment
NA
45.0
7.7
9
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.7
7.7
137
792
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
5.3
7.7
22
42
RF210
NOMESCO Finland
NA
1.8
7.7
131
748
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
7.6
422
3158
335
Kela drug reimbursment
Lapatinib
18.4
7.6
11
6
M79.7
ICD-10 Finland
Fibromyalgia
0.5
7.6
72
1332
HAC99
NOMESCO Finland
Other mastectomy
25.0
7.6
10
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.2
7.6
76
355
G47.3
ICD-10 Finland
Sleep apnoea
0.8
7.5
489
6217
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.8
7.5
642
7895
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
8.8
7.5
15
17
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
3.8
7.5
30
80
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
4.6
7.5
24
52
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.0
7.5
40
134
HAF99
NOMESCO Finland
Other operation for local recurrence of breast cancer
80.2
7.4
8
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
6.4
7.4
18
28
WX707
NOMESCO Finland
Fiberoscopic intubation
5.0
7.4
22
44
E66.8
ICD-10 Finland
Other obesity
0.6
7.3
106
1755
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.8
7.3
1090
12661
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.7
7.3
300
4059
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
6.2
7.2
18
29
8522/3-C50.5
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast
15.7
7.2
11
7
OAB39
NOMESCO Finland
Sexual health guidance
15.7
7.2
11
7
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
7.2
653
5243
R06AE07
ATC
cetirizine; oral
1.2
7.2
2335
21246
8520/3-C50.3
ICD-O-3
Lobular carcinoma, NOS, of lower-inner quadrant of breast
7.3
7.2
16
22
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
1.8
7.1
117
661
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
5.3
7.1
20
38
R10.1
ICD-10 Finland
Pain localized to upper abdomen
0.8
7.0
553
6864
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
4.7
7.0
22
47
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
4.7
7.0
22
47
C50.02
ICD-10 Finland
Malignant tumor of nipple and areola, lobular tumor
13.8
6.9
11
8
SPAT1312
SPAT
General health counselling
0.8
6.9
1117
12892
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.2
6.8
66
304
A07AA02
ATC
nystatin; oral
1.4
6.8
307
2221
1740A
ICD-9 Finland
Malignant neoplasm of female breast, Nipple and areola
9.3
6.8
13
14
WB213
NOMESCO Finland
Adjuvant hormone therapy of malignancy
40.1
6.8
8
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
4.5
6.7
22
49
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
3.3
6.7
31
94
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.0
6.7
80
406
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
0.6
6.7
77
1348
340
Kela drug reimbursment
Everolimus
22.5
6.7
9
*
N06DX01
ATC
memantine; oral
0.6
6.7
83
1425
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
6.7
120
697
G03CX01
ATC
tibolone; oral
0.6
6.6
71
1264
N06AB05
ATC
paroxetine; oral
1.4
6.6
281
2010
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.5
6.6
66
1202
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.8
6.6
107
604
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.8
6.6
454
5730
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
6.5
492
3856
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.5
6.5
43
884
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
0.7
6.4
150
2238
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
6.4
349
2604
SPAT1263
SPAT
Sampling
0.9
6.4
1660
18471
N03AG01
ATC
valproic acid; systemic, rectal
0.6
6.4
113
1788
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.4
6.4
49
203
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
0.5
6.3
59
1093
SPAT1252
SPAT
Overall medication plan or its review
0.7
6.3
142
2135
WB321
NOMESCO Finland
Multiple adjuvant therapy of malignancy with biomodifiers
11.0
6.3
11
10
HAA01
NOMESCO Finland
Suture of mammary gland
9.2
6.3
12
13
C10AX09
ATC
ezetimibe; oral
0.7
6.3
229
3159
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.1
6.3
67
325
A06AD11
ATC
lactulose; oral
1.3
6.3
588
4743
L01EF02
ATC
ribociclib; oral
+∞
6.2
6
*
NE049
NOMESCO Finland
Radiotherapy of methastasis in pelvis, sacrum or coggyx
26.7
6.2
8
*
GAC10
NOMESCO Finland
Removal of foreign body from pleural cavity
26.7
6.2
8
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
6.2
452
3523
M53.1
ICD-10 Finland
Cervicobrachial syndrome
0.8
6.2
330
4307
C01DA14
ATC
isosorbide mononitrate; oral
0.7
6.2
290
3850
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
0.7
6.2
134
2025
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
3.8
6.1
23
60
9708
FHL
Radical mastectomy (Halsted), also involves removal of the parasternal gland
8.6
6.0
12
14
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
8.6
6.0
12
14
TQD05
NOMESCO Finland
Puncture of skin of lower limb
8.6
6.0
12
14
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
4.4
6.0
20
46
I25.2
ICD-10 Finland
Old myocardial infarction
0.5
6.0
53
996
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
532
862
6.61
316.24
1.5
1.3
nmol/l
0.3
0.4
2.26
377
600
(1617658) Protocol used for examination of sentinel lymph nodes
676
623
11.93
307.65
1.0
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4919
30594
3.16
307.65
12.1
5.5
umol/l
8.9
10.3
25.74
4799
28835
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
1738
1315
17.37
307.65
5.8
2.6
u/ml
55.3
27.8
4.93
1693
1275
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1958
6260
3.98
307.65
5.1
3.6
ug/l
15.8
22.1
0.62
1502
4924
(4035726)
1869
5422
4.36
307.65
1.4
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
5153
34008
3.08
307.65
15.7
8.8
e9/l
3.4
4.0
70.49
4798
29622
(40768793) Breast Pathology biopsy report
1150
2006
6.69
307.65
1.3
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
3917
21156
2.99
307.65
8.6
3.0
mmol/l
2.4
2.4
0.32
3662
18268
(40758558) Short blood count panel - Blood
3175
15045
3.07
307.65
11.5
6.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6048
46041
3.68
282.90
13.7
7.1
u/l
74.4
78.2
9.68
5935
43109
(3002256) Pathology report gross observation
1819
7854
2.79
276.40
1.4
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1257
5076
2.81
211.44
3.6
3.6
u/ml
49.0
58.3
0.58
1225
4889
(40768804) Tissue Pathology biopsy report
3835
26320
2.04
175.03
2.5
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
560
1634
3.64
161.38
1.2
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
264
434
6.29
153.53
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2844
18222
1.96
150.65
2.1
2.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3614
27201
1.70
96.48
6.2
5.3
mmol/l
1.2
1.2
2.31
3391
24480
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3572
26805
1.69
96.40
3.7
3.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3886
30174
1.67
88.98
7.7
6.0
mmol/l
1.2
1.2
1.11
3285
25385
(3018418) pH of Serum or Plasma
2590
18294
1.67
84.42
5.3
3.7
ph
7.4
7.4
3.44
508
3368
(3023368) Bacteria identified in Blood by Culture
2051
13742
1.70
80.87
4.1
4.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2120
14569
1.66
74.67
3.5
3.5
%
95.7
95.2
0.46
2071
14140
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
175
424
4.21
65.03
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1947
13772
1.58
57.82
2.1
2.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
720
3871
1.96
56.91
1.5
1.3
iu/l
31.8
37.3
5.48
628
3398
(3024561) Albumin [Mass/volume] in Serum or Plasma
3238
25642
1.50
56.50
3.9
4.3
g/l
35.4
35.7
2.52
3040
23734
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1659
11552
1.58
51.72
3.1
2.8
mmol/l
2.5
2.5
0.85
1479
10123
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5365
58343
0.63
50.07
4.0
4.4
mmol/l
1.6
1.6
6.33
4898
53730
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5417
58739
0.63
49.05
4.0
4.4
mmol/l
4.9
4.9
0.68
4957
54348
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5551
59818
0.62
48.05
4.5
4.9
mmol/l
2.8
2.9
4.74
5046
55089
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
141
380
3.77
45.29
1.9
1.5
ug/l
1.7
4.2
1.69
90
259
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
5152
56265
0.66
44.46
3.5
3.9
mmol/l
1.3
1.3
0.17
4642
51361
(40768795) Lymph node Pathology biopsy report
187
650
2.93
39.91
1.1
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4980
54431
0.69
38.39
4.8
5.5
mmol/mol
38.9
39.3
2.71
4578
50334
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
5383
57839
0.68
35.65
4.2
4.6
mmol/l
5.8
5.8
3.29
4892
52945
(3052851) Hemolysis interference index of Serum or Plasma
353
1766
2.05
33.78
2.4
3.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
247
1091
2.31
32.34
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
247
1091
2.31
32.34
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1251
16951
0.68
32.16
3.4
3.7
mg/mmol
5.3
7.4
1.25
643
9667
(3042936) Bacteria identified in Isolate by Culture
1086
7585
1.51
31.40
1.9
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5945
55568
1.53
29.96
18.3
12.3
ml/min/173m2
82.9
79.8
33.02
5344
45791
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
811
5416
1.56
28.61
1.6
2.1
g/l
0.2
0.2
2.42
774
5054
(3012516) Albumin [Mass/volume] in Urine
1214
16142
0.70
27.14
2.8
3.1
mg/l
636.5
481.0
0.37
640
9086
(40768806) Pleura Pathology biopsy report
124
428
2.93
26.91
1.5
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
102
315
3.27
26.75
2.4
3.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1308
16956
0.72
24.66
2.6
3.0
mmol/l
6.5
6.5
0.03
1064
14175
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
241
1208
2.03
22.97
1.5
1.3
u/l
35.4
37.4
0.40
226
962
(3003434) Protein [Mass/volume] in Pleural fluid
135
535
2.55
22.52
1.4
1.4
g/l
35.9
32.6
2.63
125
484
(3044889) 12 lead EKG panel
4563
41462
1.30
22.04
3.4
3.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1150
8633
1.40
21.96
1.7
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
5223
48428
1.33
21.27
24.0
16.2
%
13.8
13.7
4.43
5177
47423
(3012441) Differential panel - Pleural fluid
108
404
2.70
20.27
1.4
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
813
5900
1.43
18.61
1.7
1.7
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
109
430
2.56
18.43
1.2
1.2
u/l
76.0
79.3
0.13
101
376
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
812
5905
1.43
18.36
1.6
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2254
19042
1.27
18.36
4.3
3.1
u/l
35.2
32.6
0.97
2154
18041
(3028308) Erythrocytes [#/volume] in Pleural fluid
108
426
2.56
18.27
1.4
1.4
e6/l
24559.7
61910.9
0.96
68
239
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
106
422
2.54
17.61
1.2
1.2
u/l
17.9
20.2
0.15
94
355
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1723
14134
1.29
17.58
1.4
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6129
58653
1.43
17.51
18.4
13.4
mg/l
21.3
21.1
0.20
5041
46103
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5376
56578
0.77
16.77
5.1
5.4
mu/l
2.3
2.0
0.35
4923
52283
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
211
1131
1.89
16.64
1.2
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2311
19753
1.26
16.63
4.7
5.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
114
486
2.37
16.36
1.4
1.4
e6/l
1461.5
2441.7
1.36
82
355
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1099
8546
1.34
16.36
2.6
2.7
e6/l
3.9
4.3
0.56
524
4372
(3002030) Lymphocytes/100 leukocytes in Blood
3173
28172
1.23
15.95
5.0
6.1
%
27.7
28.7
5.63
2971
26119
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1033
13041
0.76
14.92
1.5
1.6
pmol/l
33920642.9
32992735.0
0.02
852
10751
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
151
753
2.03
14.73
1.2
1.2
u/l
59.3
60.5
0.11
113
501
(3045788) Cell count panel - Pleural fluid
94
386
2.45
14.70
1.5
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
348
2229
1.59
14.53
1.4
1.5
pmol/l
109.2
159.5
1.58
341
2172
(3019069) Monocytes/100 leukocytes in Blood
3087
27507
1.22
14.43
5.1
6.3
%
8.8
8.3
6.99
2900
25642
(3022096) Basophils/100 leukocytes in Blood
2979
26511
1.22
13.92
4.9
6.0
%
0.7
0.7
1.40
2777
24576
(1761868) Lipid panel - Serum or Plasma
1788
20950
0.80
13.87
2.5
2.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
129
622
2.09
13.80
2.5
2.9
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
30
63
4.78
13.51
1.4
1.2
nmol/l
0.3
0.4
0.20
24
38
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1940
22470
0.81
13.37
3.7
4.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
3059
27363
1.21
13.37
4.9
6.0
%
2.6
2.8
5.12
2854
25359
(3030467) Casts [#/volume] in Urine by Automated count
1802
15291
1.24
13.14
2.8
3.0
e6/l
0.4
0.4
0.09
1307
11317
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
986
12299
0.77
12.74
1.3
1.3
iu/ml
33.4
35.4
0.16
301
4030
(3021589) Normoblasts [#/volume] in Blood
2881
25711
1.21
12.65
10.1
9.1
e9/l
0.0
0.0
1.83
2283
20948
(3018010) Neutrophils/100 leukocytes in Blood
3091
27814
1.20
12.31
4.9
5.8
%
56.6
56.8
0.36
2901
25868
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
943
11779
0.77
12.26
1.2
1.3
u/ml
10.5
12.8
0.48
368
4651
(36304419) Bacteria [Presence] in Urine
1761
15008
1.23
12.17
2.7
2.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3079
27722
1.20
12.11
2.3
2.3
nmol/l
81.1
79.5
2.71
2837
24966
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1130
9171
1.28
11.95
3.1
3.0
mmol/l
0.8
0.8
0.64
1047
8497
(3041096) Erythrocytes [Presence] in Urine by Automated
1301
15572
0.80
11.82
3.4
3.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
228
1392
1.66
11.61
1.1
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1909
16499
1.22
11.36
2.8
3.0
e6/l
110.1
61.9
0.44
1403
12355
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1527
17817
0.82
10.71
1.9
2.1
u/l
157.5
165.7
0.14
1421
16625
(3018095) Leukocytes [#/volume] in Urine
2258
19946
1.20
10.48
3.3
3.5
e6/l
77.4
114.6
2.88
1509
13610
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
656
5036
1.33
10.43
5.2
3.4
mmol/l
1.2
1.2
0.16
617
4337
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4716
49711
0.83
10.31
4.3
4.5
pmol/l
14.7
14.8
1.47
4297
45673
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1143
9459
1.25
10.11
2.4
2.5
e6/l
1.7
1.7
0.03
567
5260
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
92
449
2.06
9.67
1.9
1.5
u/l
5.0
5.6
0.15
63
207
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
169
1004
1.70
9.61
1.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
169
1005
1.70
9.58
1.3
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
814
6543
1.28
9.17
1.6
1.7
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
24
58
4.15
9.15
1.5
2.5
mg/l
1.5
1.1
0.22
14
39
(40768441) Liver Pathology biopsy report
92
462
2.00
8.98
1.1
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
6227
60579
1.31
8.96
16.5
15.0
mmol/l
139.7
139.7
0.03
6118
59100
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
229
1494
1.55
8.95
1.6
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
297
2047
1.47
8.93
2.6
3.2
u/ml
1127.8
1042.1
0.05
248
1723
(3037522) Nuclear Ab [Titer] in Serum
730
9056
0.78
8.72
1.3
1.4
titre
522.3
574.6
0.36
156
2075
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
693
5509
1.29
8.52
2.2
2.3
u/l
52.7
37.4
0.60
601
4658
(40758358) Immune stain study
18
37
4.87
8.35
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1078
12744
0.82
8.27
3.9
4.5
kg/l
1.0
1.0
0.29
149
1902
(3013115) Eosinophils [#/volume] in Blood
3305
30541
1.16
8.14
4.9
6.0
e9/l
0.2
0.2
12.22
2838
26809
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
422
3152
1.36
8.06
1.7
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2680
29264
0.86
8.03
3.5
3.9
estimate
0.0
0.0
0.50
463
5191
(3005719) IgG [Mass/volume] in Serum or Plasma
314
4339
0.71
7.96
2.6
2.9
g/l
10.8
10.3
0.87
287
3989
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
701
5633
1.27
7.90
3.3
3.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1262
14638
0.83
7.89
1.9
2.3
umol/l
4917.8
4079.3
0.30
1068
12563
(3023103) Potassium [Moles/volume] in Serum or Plasma
6231
60753
1.28
7.82
16.6
15.1
mmol/l
3.9
3.9
7.38
6111
59158
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
55
240
2.30
7.71
2.2
3.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
3261
30184
1.15
7.67
4.9
5.8
e9/l
1.7
1.9
12.11
2818
26551
(3035880) pH of Pleural fluid
49
205
2.40
7.55
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
254
3595
0.70
7.41
1.6
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4322
45471
0.87
7.38
3.7
4.3
mm/h
12.8
12.8
0.10
3959
42218
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
599
4773
1.28
7.22
4.1
2.5
ml/min/173m2
71.0
65.9
3.28
236
1936
(3008898) HLA-B27 [Presence]
135
2163
0.62
7.21
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
1227
10576
1.19
7.05
2.6
2.7
mosm/kgh2o
509.2
505.4
0.25
1050
8928
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
56
257
2.19
7.00
1.3
1.2
u/l
10.9
11.1
0.06
51
231
(3021601) Nitrite [Presence] in Urine by Test strip
2723
29511
0.87
6.96
4.7
5.3
estimate
0.0
0.0
1.60
465
5217
(3019832) Treponema pallidum Ab [Presence] in Serum
191
2817
0.67
6.95
1.3
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2749
29769
0.87
6.94
3.5
4.0
estimate
0.0
0.0
1.80
468
5252
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1228
14136
0.84
6.93
1.2
1.3
u/ml
1.0
1.5
1.86
276
3838
(3014111) Lactate [Moles/volume] in Serum or Plasma
554
4397
1.28
6.90
4.6
6.2
mmol/l
1.3
1.3
0.05
531
4262
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
503
6330
0.78
6.69
1.6
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
301
4068
0.73
6.68
1.6
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
201
2892
0.69
6.45
1.2
1.3
u/ml
2.3
1.1
0.34
16
273
(3001964) Herpes simplex virus Ag [Presence] in Specimen
40
166
2.42
6.33
1.1
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
3169
29515
1.14
6.31
4.8
5.8
e9/l
0.0
0.0
0.87
2681
25458
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1964
21665
0.87
6.30
2.9
3.4
ng/l
27.5
61.1
0.83
1282
13795
(3029937) Albumin [Presence] in Urine by Test strip
1378
15588
0.85
6.19
3.7
4.5
estimate
0.0
0.0
2.12
463
5230
(4281824)
155
1012
1.54
6.16
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
353
4602
0.75
6.15
1.2
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
3152
29394
1.13
6.06
4.8
5.8
e9/l
0.5
0.6
1.76
2671
25374
(3048689) Calprotectin [Mass/mass] in Stool
642
7750
0.81
5.92
2.0
2.1
ug/g
113.2
123.7
0.35
476
6023
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
143
2156
0.66
5.86
1.8
1.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
252
3422
0.73
5.80
1.9
1.8
g/l
1.2
1.3
0.45
232
3117
(3009214) Lutropin [Units/volume] in Serum or Plasma
138
897
1.55
5.64
1.4
1.2
u/l
18.0
20.0
0.71
114
722
(3003694) ABO and Rh group [Type] in Blood
1569
14033
1.15
5.56
1.3
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2378
21915
1.13
5.32
5.4
7.6
inr
1.1
1.2
5.63
672
6274
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
19
58
3.28
5.29
1.4
1.4
%
8.9
11.2
0.19
14
24
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
174
1206
1.45
5.25
1.3
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2437
26265
0.89
5.15
2.5
2.8
ug/l
153.1
100.7
7.89
2274
24367
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
168
1166
1.45
5.05
1.3
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
77
1269
0.60
4.76
1.4
1.4
e6/l
1800.6
1298.9
0.22
53
1034
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
77
1266
0.60
4.71
1.4
1.4
e6/l
28.8
30.7
0.04
49
975
(3019309) Folate [Moles/volume] in Red Blood Cells
962
10963
0.86
4.63
1.7
1.7
nmol/l
1131.0
1195.0
1.29
705
8280
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
121
1792
0.67
4.62
1.7
1.6
iu/ml
0.2
9.0
0.50
36
377
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1504
13582
1.14
4.53
1.6
1.7
mg/l
1.1
1.1
0.55
1150
10399
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
129
870
1.49
4.52
1.4
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
137
1970
0.69
4.49
1.4
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
37
739
0.50
4.48
1.1
1.1
iu/ml
39.8
14815.6
—
6
161
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1717
18761
0.89
4.41
2.2
2.5
u/l
58.3
57.2
0.22
1564
17180
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1473
16243
0.88
4.39
1.6
1.6
mmol/l
1.4
1.4
0.07
1264
13647
(3009542) Hematocrit [Volume Fraction] of Blood
5432
52822
1.14
4.35
21.1
14.5
%
38.5
39.0
5.38
4204
37944
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
388
4776
0.80
4.32
1.1
1.2
iu/ml
160.7
150.8
0.20
160
1915
(3036481) Cortisol [Moles/volume] in Serum or Plasma
483
5798
0.82
4.23
2.1
2.1
nmol/l
407.4
373.7
2.57
440
5285
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
24
96
2.50
4.20
1.4
1.2
ug/l
773.8
181.2
0.40
19
60
(3013826) Glucose [Moles/volume] in Serum or Plasma
3473
32989
1.11
4.18
3.7
4.2
mmol/l
6.5
6.6
3.82
3317
30798
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
246
1884
1.32
4.13
1.8
2.0
ug/l
1.5
1.8
0.28
213
1656
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6346
62490
1.21
4.05
16.9
10.3
u/l
24.5
24.1
0.64
6235
60309
(3029634) Reagin Ab [Titer] in Serum by VDRL
26
565
0.46
4.04
1.5
1.5
—
2.8
—
0
5
(40768443) Skin Pathology biopsy report
349
2819
1.25
3.87
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
99
657
1.51
3.81
1.3
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
645
7471
0.85
3.80
4.3
4.5
%
34.1
33.3
1.12
413
4973
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
771
6726
1.16
3.77
2.4
2.4
umol/l
9.1
7.2
1.05
639
5720
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
41
747
0.55
3.76
1.3
1.2
u/l
15.3
25.4
2.36
34
649
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
5
12.01
3.76
6.3
5.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
5
12.01
3.76
3.2
2.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
285
2256
1.27
3.76
1.9
2.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
324
3994
0.80
3.69
1.3
1.3
u/ml
229.6
166.0
0.69
291
3690
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
191
2513
0.75
3.67
1.4
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
100
1458
0.68
3.61
1.5
1.6
mu/l
291.2
323.7
0.60
91
1297
(21494755) Public health laboratory ask at order entry panel
429
5126
0.83
3.61
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
263
2074
1.28
3.59
1.8
1.8
—
—
—
0
0
(3019225) pH of Specimen
705
6132
1.17
3.59
5.6
4.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
375
3085
1.23
3.54
1.2
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
507
4295
1.19
3.54
1.5
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1308
14348
0.89
3.48
2.1
2.3
mg/l
2.9
3.0
1.52
1118
12312
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
30
586
0.51
3.48
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
69
1076
0.64
3.47
2.0
2.4
ug/min
29.4
65.7
1.84
39
605
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
85
559
1.53
3.45
1.3
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
330
4025
0.81
3.42
2.9
3.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
729
6385
1.16
3.40
5.5
6.3
mmol/l
104.3
104.2
0.21
721
6254
(3007164) IgA [Mass/volume] in Serum or Plasma
1071
11869
0.88
3.38
1.4
1.4
g/l
2.2
2.3
1.48
541
7031
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
60
957
0.62
3.35
2.8
1.9
nmol/l
0.7
0.8
0.94
52
796
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
82
539
1.53
3.35
1.4
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
384
3191
1.22
3.31
5.9
7.9
%
94.3
94.0
0.41
384
3178
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
639
0.55
3.28
1.2
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
32
162
1.98
3.28
1.3
1.9
e6/l
1414.6
26218.1
1.09
21
80
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
38
676
0.56
3.26
1.2
1.1
—
—
—
0
0
(4010399)
377
4508
0.83
3.22
1.4
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
78
513
1.53
3.19
1.3
1.6
—
—
—
0
0
(3013512) EKG study
1577
17048
0.90
3.18
3.4
3.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
205
1596
1.29
3.14
1.9
2.0
%
95.0
95.3
0.07
185
1467
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
144
1924
0.74
3.13
1.5
1.8
g/l
0.2
0.2
0.12
133
1820
(3033799) Differential panel - Peritoneal fluid
31
158
1.97
3.13
1.2
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
555
6402
0.86
3.13
1.5
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
484
4132
1.18
3.13
5.7
7.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
157
2070
0.75
3.12
1.2
1.3
u/ml
9.8
38.6
—
5
144
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
376
4482
0.83
3.12
2.3
2.4
au/ml
34.1
28.1
0.28
26
276
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
139
1864
0.74
3.10
1.2
1.3
u/ml
8.4
6.8
0.08
14
211
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
110
1527
0.72
3.07
1.2
1.3
u/ml
1.0
3.8
—
8
122
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2324
24620
0.91
3.04
1.9
2.0
pmol/l
97.7
99.4
0.84
1098
11659
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
142
1889
0.75
3.01
1.2
1.3
u/ml
3.0
6.6
2.06
24
329
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
101
1417
0.71
3.01
1.3
1.3
mg/l
549.4
499.3
0.50
96
1355
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
66
1003
0.65
3.00
1.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
26
504
0.51
3.00
1.4
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
798
8936
0.88
2.97
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
241
2989
0.80
2.96
4.1
3.6
—
—
—
0
0
(3036489) Thrombin time
248
1993
1.25
2.96
1.9
1.9
s
21.8
21.1
1.17
217
1717
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
28
526
0.53
2.93
1.8
1.5
%
25.4
35.1
0.85
17
296
(3015736) pH of Urine
2140
22721
0.92
2.91
3.2
3.7
ph
5.8
5.8
—
6
6
(3004809) Band form neutrophils/100 leukocytes in Blood
120
875
1.38
2.90
2.0
3.2
%
2.3
1.3
1.56
96
681
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
88
1254
0.70
2.88
1.3
1.3
mmol/l
3.6
3.7
0.55
81
1187
(3014891) Appearance of Pleural fluid
15
58
2.59
2.87
1.3
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
48
774
0.62
2.86
1.3
1.2
mmol/l
7.9
7.5
0.41
38
574
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
73
1075
0.68
2.85
1.2
1.3
—
88.6
—
0
21
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
429
0.49
2.85
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
23
454
0.50
2.82
2.3
2.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1258
11538
1.11
2.82
2.2
2.5
e6/l
8.4
7.3
1.04
1098
10018
(3031040) Bacteria [#/volume] in Urine by Automated count
4070
39327
1.09
2.82
4.5
4.7
e6/l
1674.2
2811.5
0.38
45
480
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3721
38568
0.92
2.80
2.9
3.0
u/l
53.8
42.9
5.12
3451
35812
(3018677) aPTT in Platelet poor plasma by Coagulation assay
880
7917
1.13
2.78
2.0
2.0
s
29.1
29.4
0.81
858
7670
(3048929) Epstein Barr virus Ab [Presence] in Serum
98
1360
0.72
2.76
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
235
2894
0.81
2.73
1.9
1.9
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
56
356
1.58
2.71
1.2
1.1
u/l
24.1
21.5
0.13
48
274
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
153
1981
0.77
2.71
1.5
1.7
g/l
1.2
1.2
0.23
140
1877
(3000963) Hemoglobin [Mass/volume] in Blood
6410
64710
0.85
2.70
28.8
20.1
g/l
129.1
132.4
97.03
6354
63827
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
345
4086
0.84
2.70
1.2
1.3
au/ml
63.0
42.7
0.63
16
191
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
69
461
1.50
2.68
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
69
461
1.50
2.68
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
69
461
1.50
2.68
1.3
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
134
1762
0.76
2.66
1.3
1.3
miu/ml
213.4
220.2
0.08
64
847
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
56
358
1.57
2.66
1.2
1.1
u/l
85.5
77.6
0.28
48
281
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
668
7504
0.88
2.62
7.3
6.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
61
913
0.67
2.62
1.2
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
376
4406
0.84
2.61
2.1
2.3
ug/l
3.2
5.9
13.37
309
3745
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
181
1425
1.28
2.60
2.2
2.4
g/l
3.3
3.6
3.15
172
1355
(3023487) Leukocytes [#/volume] in Peritoneal fluid
33
184
1.80
2.60
1.4
2.1
e6/l
794.0
3714.0
0.51
24
119
(3026361) Erythrocytes [#/volume] in Blood
6410
64696
0.85
2.60
28.7
20.0
e12/l
4.3
4.4
105.05
6297
62879
(3010813) Leukocytes [#/volume] in Blood
6411
64704
0.85
2.59
28.7
20.0
e9/l
6.2
6.5
3.27
6298
62879
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
11
38
2.90
2.58
1.1
1.6
%
51.5
68.7
—
6
26
(46235355) HIV 1 and 2 tests - Meaningful Use set
643
7232
0.88
2.57
1.6
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
60
897
0.67
2.57
1.1
1.2
u/ml
266.7
289.7
0.28
38
562
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
120
1593
0.75
2.56
1.2
1.3
u/ml
25.8
46.1
1.16
11
188
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
171
1340
1.28
2.56
2.1
1.7
u/l
1174.6
2919.3
1.01
54
488
(3017143) Hepatitis C virus Ab [Presence] in Serum
480
5507
0.86
2.56
1.5
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
6410
64688
0.86
2.53
28.6
19.9
fl
91.9
91.1
37.01
6353
63785
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
68
989
0.68
2.53
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
65
953
0.68
2.53
1.1
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
21
101
2.08
2.52
1.1
1.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
6410
64685
0.86
2.51
28.6
19.9
pg
30.4
30.2
18.60
6353
63779
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
77
534
1.45
2.51
1.4
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
22
421
0.52
2.49
1.8
1.9
%
13.6
14.0
—
10
178
(3020630) Protein [Mass/volume] in Serum or Plasma
513
4493
1.15
2.45
2.9
2.5
g/l
66.3
66.6
0.48
464
4049
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
35
583
0.60
2.44
1.3
1.1
—
40.2
—
0
5
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
310
2611
1.20
2.40
6.4
8.1
mmol/l
24.5
24.5
0.10
287
2437
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
204
2506
0.81
2.36
1.6
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
6410
64659
0.86
2.32
28.7
20.0
e9/l
256.0
263.8
20.25
6308
63026
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
58
387
1.50
2.32
1.3
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
47
721
0.65
2.31
1.6
1.6
%
56.5
54.6
0.13
31
434
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
58
851
0.68
2.30
1.5
1.3
nmol/l
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
30
509
0.59
2.27
1.8
2.7
mg/l
22.5
33.9
0.28
17
349
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
493
5587
0.87
2.24
1.4
1.6
%
1.3
1.4
0.55
430
4909
(40761535) Cells panel - Urine sediment
424
4855
0.86
2.23
3.0
3.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
143
1118
1.28
2.23
1.4
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
77
1066
0.72
2.21
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
36
2.78
2.20
1.5
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
14
297
0.47
2.19
1.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
61
876
0.69
2.17
1.7
1.5
mu/l
89.1
52.1
0.29
50
786
(44816559) Phosphatidylethanol [Mass/volume] in Blood
63
899
0.70
2.17
1.0
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
406
4651
0.86
2.16
3.0
3.2
pmol/l
4.5
4.4
0.28
358
4088
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
45
289
1.56
2.15
1.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
45
289
1.56
2.15
1.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
45
289
1.56
2.15
1.4
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
27
151
1.79
2.15
1.4
2.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
67
944
0.71
2.15
1.3
1.3
u/ml
56.0
59.4
—
5
79
(3034770) Mitochondria Ab [Titer] in Serum
132
1682
0.78
2.13
1.2
1.2
titre
481.4
872.7
—
7
81
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
45
290
1.56
2.13
1.4
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
241
2876
0.83
2.12
1.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
57
389
1.47
2.07
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
29
483
0.60
2.07
1.2
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
57
815
0.70
2.01
1.5
1.3
pmol/l
489.1
336.6
0.28
44
628
(3027456) Digoxin [Moles/volume] in Serum or Plasma
82
1104
0.74
2.00
3.4
3.2
nmol/l
0.8
0.8
0.22
68
846
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
196
1613
1.22
1.99
2.2
2.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
30
488
0.61
1.96
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
31
187
1.66
1.93
1.0
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
5031
49321
1.07
1.91
25.6
17.4
g/l
330.1
330.5
3.77
5003
48985
(3011412) CD3 cells [#/volume] in Blood
34
533
0.64
1.91
1.7
2.3
e9/l
1.1
1.2
0.50
19
326
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
23
397
0.58
1.91
1.5
1.5
u/l
5.3
5.2
0.10
17
333
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
37
235
1.58
1.89
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
279
3248
0.85
1.87
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
123
1550
0.79
1.86
1.3
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
757
6923
1.10
1.83
1.3
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
115
1457
0.79
1.82
2.1
2.2
—
—
—
0
0
(44790047)
74
544
1.36
1.82
1.2
1.4
—
—
—
0
0
(44790049)
74
544
1.36
1.82
1.2
1.4
—
—
—
0
0
(44806118)
74
544
1.36
1.82
1.2
1.4
—
—
—
0
0
(44790048)
74
544
1.36
1.82
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
70
949
0.73
1.82
1.2
1.3
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
36
550
0.65
1.81
1.4
1.4
e6/l
207513.9
110090.0
0.31
20
371
(3007566) Smooth muscle Ab [Titer] in Serum
134
1666
0.80
1.81
1.2
1.2
titre
150.6
152.9
0.01
16
147
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
556
5005
1.12
1.81
2.6
3.2
ng/l
77.9
81.6
0.61
480
4236
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
62
855
0.72
1.80
1.2
1.3
u/ml
118.1
117.1
0.03
15
197
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
24
402
0.60
1.79
1.7
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
234
0.47
1.78
2.0
1.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
218
2574
0.84
1.75
2.0
2.1
u/l
42.5
40.0
1.01
199
2298
(3007930) Methemoglobin/Hemoglobin.total in Blood
172
2074
0.82
1.74
4.0
5.0
%
0.9
0.9
0.57
159
1948
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
48
0.00
1.69
0.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
48
0.00
1.69
0.0
1.0
—
8.1
—
0
48
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
320
0.56
1.69
1.3
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
176
0.45
1.69
1.5
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
145
0.41
1.64
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
204
2404
0.84
1.63
2.8
3.0
mmol/l
26.1
25.5
2.18
198
2343
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
175
2090
0.83
1.62
4.0
4.9
%
1.5
1.6
1.78
163
1960
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
40
582
0.69
1.61
1.2
1.1
—
104.8
—
0
8
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
190
0.47
1.60
1.3
1.7
ug/l
7.9
8.6
—
9
190
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
36
533
0.67
1.59
1.2
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
90
1151
0.78
1.58
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
36
532
0.67
1.58
1.2
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
71
936
0.76
1.57
1.3
1.5
g/l
0.5
0.6
1.15
53
699
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
174
1455
1.20
1.57
2.1
2.3
g/l
0.0
0.0
0.00
153
1335
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
36
531
0.68
1.56
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
36
531
0.68
1.56
1.2
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
82
630
1.31
1.55
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
28
434
0.64
1.55
1.5
1.8
umol/l
10.6
7.8
0.15
19
307
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
21
348
0.60
1.54
1.3
2.8
e6/l
585.2
763.2
—
9
157
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
105
1311
0.80
1.52
2.3
2.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
102
1277
0.80
1.52
3.0
3.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
71
930
0.76
1.51
1.2
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
142
1170
1.22
1.50
2.8
3.2
u/ml
107.2
671.6
1.56
132
1052
(3024932) HLA-DR beta [Type]
5
129
0.39
1.48
1.8
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
527
4791
1.11
1.47
5.5
7.2
g/l
118.5
119.2
0.39
510
4612
(4024509)
50
687
0.73
1.47
1.6
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
64
847
0.75
1.47
1.3
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
111
893
1.25
1.47
1.8
2.7
umol/l
39.9
32.7
1.53
88
769
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
40
570
0.70
1.46
1.3
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
10
45
2.22
1.46
1.8
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
23
140
1.64
1.44
1.2
1.1
—
—
—
0
0
(4027681)
19
316
0.60
1.43
1.6
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
161
1911
0.84
1.43
1.3
1.4
ug/g
279.4
287.6
0.21
103
1061
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
26
164
1.59
1.42
7.1
3.0
ng/l
43.3
155.6
1.35
11
49
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
15
265
0.56
1.42
1.6
2.9
%
46.5
41.7
—
6
89
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
175
1481
1.19
1.41
2.1
2.3
g/l
0.0
0.0
0.66
153
1341
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
152
1811
0.84
1.41
1.7
1.8
iu/l
6.1
9.0
0.27
55
681
(3004451) EKG impression Narrative
14
251
0.56
1.40
1.1
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
136
0.44
1.39
1.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
138
1656
0.83
1.39
2.2
2.1
mg/l
10.3
11.4
0.83
132
1529
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
259
2265
1.15
1.39
3.3
3.8
mmol/l
24.6
24.5
0.21
233
2033
(3006922) Hepatitis E virus Ab [Presence] in Serum
25
386
0.65
1.39
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
57
424
1.35
1.37
3.6
2.7
ug/l
1.4
0.7
0.53
38
247
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
36
515
0.70
1.37
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
47
642
0.73
1.36
1.4
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
69
890
0.77
1.34
1.4
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
32
466
0.69
1.34
1.3
1.3
u/ml
0.6
1.4
0.58
12
209
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
209
0.53
1.34
1.2
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
9
42
2.14
1.33
1.1
1.0
u/l
7.6
14.3
—
9
42
(3003396) Base excess in Arterial blood by calculation
632
5832
1.09
1.32
5.1
6.5
mmol/l
0.9
1.2
2.08
522
4651
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
31
452
0.68
1.31
1.2
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
633
5845
1.09
1.31
5.1
6.5
kpa
14.5
12.7
8.68
601
5579
(3014271) Vancomycin [Susceptibility]
37
258
1.44
1.30
2.3
3.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
50
671
0.74
1.30
2.2
2.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
633
5848
1.09
1.29
5.1
6.5
kpa
5.1
5.1
0.20
603
5588
(3022145) Colonoscopy Study observation
640
6909
0.92
1.28
1.3
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
6
133
0.45
1.27
1.3
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2116
20384
1.05
1.27
3.1
3.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
33
472
0.70
1.27
1.2
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
31
448
0.69
1.26
1.2
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1522
15922
0.94
1.25
2.4
2.8
ng/l
1123.1
1107.4
0.04
1304
13534
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
76
958
0.79
1.25
1.4
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
98
1200
0.81
1.24
1.3
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
17
100
1.70
1.23
1.2
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
16
265
0.60
1.22
5.4
10.8
nmol/l
604.1
875.2
1.64
16
255
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
192
2211
0.86
1.22
1.5
1.6
g/l
1.8
1.6
1.16
157
1876
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
33
229
1.44
1.21
1.5
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
33
229
1.44
1.21
1.5
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
22
337
0.65
1.21
1.2
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
706
0.76
1.19
4.0
5.3
umol/l
338.7
375.5
1.15
47
608
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
44
592
0.74
1.19
1.2
1.1
—
4.4
—
0
8
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
140
1648
0.85
1.18
2.8
3.2
ratio
1.4
1.5
—
7
139
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
168
0.54
1.18
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
23
346
0.66
1.17
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
15
249
0.60
1.17
1.3
1.1
miu/ml
1484.3
1544.4
0.08
15
249
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
108
894
1.21
1.16
1.3
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
8
39
2.05
1.15
1.1
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
33
232
1.42
1.14
1.5
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
18
284
0.63
1.14
1.2
1.4
nmol/l
128.2
131.9
0.15
18
284
(3023520) Reticulocytes [#/volume] in Blood
384
4218
0.90
1.14
2.1
2.5
e9/l
72.8
70.9
0.38
279
3151
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
152
0.53
1.13
1.5
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
26
379
0.68
1.13
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
32
449
0.71
1.13
1.2
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
61
778
0.78
1.13
1.2
1.3
—
34.1
—
0
7
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
23
343
0.67
1.13
1.1
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
30
2.33
1.12
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
30
2.33
1.12
1.0
1.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
25
366
0.68
1.12
1.5
2.5
e6/l
520.1
502.8
0.06
18
304
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
154
1788
0.86
1.11
1.9
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
32
447
0.71
1.11
1.2
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
321
3552
0.90
1.10
1.3
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
50
652
0.77
1.10
1.1
1.1
—
1.4
—
0
6
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
146
1699
0.86
1.09
2.8
3.3
mg/l
27.8
38.4
1.42
121
1374
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
28
193
1.45
1.08
1.6
1.6
ug/l
0.3
0.4
0.46
23
124
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
304
0.66
1.08
1.1
1.1
u/l
1.0
1.1
0.60
11
143
(3037756) Immunofixation for Serum or Plasma
92
1114
0.82
1.08
1.9
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
183
1596
1.15
1.08
2.1
2.3
g/l
0.0
0.0
0.71
161
1451
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
10
52
1.92
1.06
11.4
12.5
mmol/l
4.4
4.5
—
10
52
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
33
2.12
1.05
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
410
4462
0.91
1.03
3.2
4.1
%
0.7
0.4
0.26
144
1004
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
33
238
1.39
1.02
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
85
698
1.22
1.02
1.3
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3988
40584
0.96
1.01
4.2
4.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
190
1672
1.14
1.00
2.0
2.2
g/l
38.1
37.9
0.24
161
1416
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
61
484
1.26
0.99
5.3
6.1
—
—
—
0
0
(4062490)
47
607
0.77
0.99
1.1
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
19
285
0.67
0.98
1.1
1.5
nmol/l
1.8
1.2
0.98
13
223
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
72
883
0.81
0.98
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
125
1456
0.86
0.97
1.6
1.6
e6/l
11761.8
11385.3
0.04
82
1045
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
49
380
1.29
0.96
1.8
1.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
148
1699
0.87
0.95
2.8
3.3
mg/l
32.9
84.7
0.91
122
1378
(3044927) Protein electrophoresis panel - Urine
42
547
0.77
0.95
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
94
788
1.20
0.93
5.9
4.4
ug/l
2.1
2.5
0.30
72
613
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
209
1864
1.12
0.92
1.1
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
48
608
0.79
0.89
1.1
1.4
g/l
0.4
0.4
0.16
33
426
(3027135) IgG subclass 1 [Mass/volume] in Serum
48
608
0.79
0.89
1.1
1.4
g/l
6.8
6.6
0.15
33
425
(4034850)
180
2026
0.89
0.88
11.3
9.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
48
607
0.79
0.88
1.1
1.4
g/l
2.8
2.8
0.00
33
424
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
230
0.65
0.88
3.6
4.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
72
870
0.83
0.87
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
31
229
1.36
0.86
1.2
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
31
229
1.36
0.86
1.2
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
275
3015
0.91
0.85
2.6
3.1
g/l
124.8
127.1
1.18
269
2948
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
321
0.72
0.84
1.1
1.1
—
—
—
0
0
(4146454)
45
569
0.79
0.84
3.2
2.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
91
1071
0.85
0.84
1.3
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
66
799
0.82
0.83
1.4
2.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
8
139
0.57
0.83
1.0
1.4
umol/l
18.1
17.5
—
8
125
(3013293) Extractable nuclear Ab [Presence] in Serum
8
139
0.57
0.83
1.0
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
113
0.53
0.83
1.0
1.1
—
336.0
—
0
5
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
43
545
0.79
0.82
1.1
1.2
u/ml
13.3
47.0
—
7
50
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
27
365
0.74
0.82
1.1
1.0
ng/l
36.8
44.9
0.71
19
248
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
165
0.61
0.81
1.6
3.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
148
1675
0.88
0.81
1.8
2.2
ug/l
147.0
536.8
2.38
136
1546
(3045424) Erythrocytes [Presence] in Urine
91
1067
0.85
0.81
1.5
1.6
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
14
213
0.66
0.81
1.2
1.1
—
0.3
—
0
12
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
20
283
0.71
0.80
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
209
1883
1.11
0.80
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
118
1025
1.15
0.80
1.5
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
82
692
1.19
0.79
1.9
2.8
—
—
—
0
0
(3024316) Viscosity of Plasma
0
24
0.00
0.79
0.0
1.3
—
1.6
—
0
16
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.8
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
33
1.82
0.79
1.7
2.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
27
362
0.74
0.78
1.1
1.0
ng/l
772.8
724.4
0.25
18
241
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
26
0.00
0.78
0.0
1.7
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
71
846
0.84
0.77
1.2
1.2
u/ml
3.1
3.9
0.44
26
342
(3016502) Oxygen saturation in Arterial blood
542
5100
1.07
0.77
5.3
6.9
%
96.2
95.9
0.65
524
4907
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
34
1.77
0.76
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
124
1412
0.88
0.76
5.4
4.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
209
1890
1.11
0.76
1.1
1.2
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
28
0.00
0.76
0.0
1.0
—
109.9
—
0
16
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
183
1643
1.12
0.76
1.2
1.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
34
261
1.30
0.76
1.1
1.0
%
99.2
94.5
0.55
28
205
(3000093) Morphology [Interpretation] in Blood Narrative
35
449
0.78
0.75
1.2
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
27
359
0.75
0.75
1.1
1.0
ng/l
298.8
368.4
1.02
20
246
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
63
756
0.83
0.74
1.1
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
24
2.08
0.74
1.0
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
24
324
0.74
0.74
2.0
2.0
ug/l
3.5
2.9
0.20
19
281
(3004588) Protein electrophoresis panel - Serum or Plasma
354
3809
0.93
0.74
2.1
2.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
339
3142
1.08
0.73
1.5
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
50
613
0.81
0.73
1.3
1.4
mosm/kgh2o
273.2
275.9
0.33
35
466
(1002224) Polysomnography panel
212
2332
0.91
0.73
1.1
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
260
2831
0.92
0.72
2.3
3.3
mmol/l
2.2
2.0
0.33
205
2176
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
73
616
1.19
0.72
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
476
5058
0.94
0.71
1.1
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
200
1813
1.11
0.71
2.1
2.3
g/l
0.8
0.7
0.04
173
1550
(3021960) Folate [Moles/volume] in Serum or Plasma
1313
13578
0.96
0.70
1.5
1.5
nmol/l
21.8
21.6
0.21
1131
11499
(3019977) pH of Arterial blood
20
275
0.73
0.70
1.5
3.3
ph
7.4
7.4
—
9
94
(3039443) Prostate specific Ag panel - Serum or Plasma
7
41
1.71
0.70
1.3
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
17
240
0.71
0.69
1.1
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
314
3384
0.92
0.69
2.4
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1130
10888
1.05
0.69
3.2
3.5
ng/l
157.5
257.4
1.37
865
7950
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
16
228
0.70
0.69
1.2
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
30
230
1.31
0.69
1.2
1.1
iu/ml
—
3.3
—
0
10
(3002179) Metamyelocytes/100 leukocytes in Blood
420
4475
0.93
0.69
2.9
3.9
%
1.2
0.6
4.19
125
925
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
157
0.64
0.68
1.4
3.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
157
0.64
0.68
1.4
3.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
166
1841
0.90
0.68
2.1
2.9
g/l
0.2
0.3
0.40
58
611
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
29
375
0.77
0.68
1.1
1.1
nmol/l
1.1
9.3
—
7
69
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
110
1.46
0.68
1.9
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
429
4565
0.94
0.68
2.2
2.8
ng/l
152.1
168.1
0.54
391
4153
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
158
1756
0.90
0.68
1.0
1.1
u/ml
1.2
8.3
3.75
20
218
(3016879) Cocaine [Presence] in Urine
97
1111
0.87
0.67
1.3
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
272
2943
0.92
0.67
2.3
3.3
ph
7.4
7.4
1.52
33
405
(3019060) Gas panel - Arterial blood
310
3336
0.93
0.67
3.5
4.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
276
2984
0.92
0.67
2.4
3.3
kpa
5.2
5.2
0.27
249
2754
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
31
396
0.78
0.66
1.7
2.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
145
1617
0.89
0.66
4.2
5.9
mmol/l
1.3
1.3
0.38
131
1438
(3047189) Immunofixation for 24 hour Urine
16
226
0.71
0.66
2.9
1.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
94
0.53
0.66
1.0
1.9
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
155
0.64
0.65
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
155
0.64
0.65
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
155
0.64
0.65
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
155
0.64
0.65
1.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
45
549
0.82
0.65
6.5
4.7
mmol/l
6.9
7.4
0.59
39
453
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
32
250
1.28
0.65
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
57
476
1.20
0.65
3.2
3.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
94
819
1.15
0.65
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
94
820
1.15
0.64
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
20
270
0.74
0.64
1.8
1.8
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
25
189
1.32
0.64
1.1
1.1
%
99.8
92.1
—
9
72
(3042111) Morphology [Interpretation] in Bone marrow Narrative
71
827
0.86
0.63
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
70
598
1.17
0.63
4.5
4.1
%
22.5
22.1
0.08
32
256
(3003888) Timothy IgE Ab [Units/volume] in Serum
77
891
0.86
0.63
1.1
1.1
u/ml
4.3
3.1
0.41
33
404
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
480
0.81
0.62
2.2
2.2
u/field
4.1
2.1
0.68
16
208
(4015189)
10
152
0.66
0.61
1.5
2.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
41
500
0.82
0.60
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
187
0.69
0.60
1.4
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
101
1142
0.88
0.60
4.8
6.9
mmol/l
105.7
105.0
0.67
89
1027
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
112
995
1.13
0.60
2.3
3.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
48
575
0.83
0.59
1.1
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
101
1141
0.88
0.59
4.8
6.9
mmol/l
11.0
11.0
0.04
89
1026
(3021788) Differential panel - Synovial fluid
96
1087
0.88
0.59
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
65
556
1.17
0.59
1.2
1.3
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
1.6
—
0
17
(3020874) Milk IgE Ab [Units/volume] in Serum
26
332
0.78
0.58
1.1
1.0
u/ml
0.3
1.4
—
6
98
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
300
1.23
0.58
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
108
1211
0.89
0.57
1.3
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
46
550
0.84
0.57
1.2
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
18
241
0.75
0.56
2.5
2.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
34
274
1.24
0.56
1.5
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
23
297
0.77
0.56
1.1
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
88
998
0.88
0.56
1.8
4.8
iu/ml
237.8
736.7
—
6
130
(3030981) Hyaline casts [#/volume] in Urine by Automated count
249
2677
0.93
0.56
2.6
2.5
e6/l
0.2
0.3
2.43
236
2576
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
195
0.72
0.56
2.3
2.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
23
296
0.78
0.55
1.3
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
36
293
1.23
0.55
1.3
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
73
837
0.87
0.55
2.3
2.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
68
783
0.87
0.54
2.1
2.2
mg/l
30.9
26.8
0.22
15
210
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
24
186
1.29
0.54
1.1
1.1
%
111.3
96.0
—
8
75
(40761536) Microorganisms panel - Urine sediment
461
4848
0.95
0.53
3.8
4.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
74
1.49
0.53
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
43
513
0.84
0.53
1.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
161
1758
0.91
0.53
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
166
1521
1.09
0.52
2.6
3.1
u/ml
0.4
0.4
0.16
94
867
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
81
918
0.88
0.52
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
43
512
0.84
0.52
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
43
512
0.84
0.52
1.0
1.2
—
—
—
0
0
(4198724)
9
134
0.67
0.51
1.1
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
40
1.50
0.51
1.7
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
46
543
0.85
0.51
1.2
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
110
1221
0.90
0.51
3.5
3.6
mg/l
20.1
23.7
0.70
71
753
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
33
269
1.23
0.51
1.5
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
75
852
0.88
0.51
3.3
2.7
%
13.3
13.3
0.13
75
839
(3028433) Virus identified in Specimen by Culture
25
197
1.27
0.50
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
191
0.73
0.50
1.9
1.8
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
43
510
0.84
0.50
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
43
510
0.84
0.50
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
51
435
1.17
0.50
1.9
2.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
43
509
0.84
0.49
1.0
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
17
127
1.34
0.49
1.1
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
79
698
1.13
0.49
4.3
4.7
u/ml
181.3
114.8
0.26
23
200
(3043410) Blood group antigens tested for on Red Blood Cells
18
136
1.32
0.49
1.7
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
107
0.65
0.48
1.3
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
17
223
0.76
0.48
1.4
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
34
410
0.83
0.48
1.2
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
42
354
1.19
0.47
1.1
1.1
ratio
1.0
1.1
0.86
28
129
(40765089) Chromosome analysis panel - Blood by G-banded
7
48
1.46
0.46
1.0
1.0
—
—
—
0
0
(3010421) pH of Blood
148
1360
1.09
0.46
2.5
3.3
ph
7.4
7.4
0.42
117
1127
(3027008) Opiates [Presence] in Urine
111
1222
0.91
0.45
1.3
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
55
632
0.87
0.45
1.9
2.0
pg
32.9
32.4
0.40
55
627
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
153
0.72
0.45
1.5
2.1
ug/l
0.9
1.1
0.44
11
147
(3048879) Bone marrow aspiration report
10
141
0.71
0.44
1.2
2.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
15
112
1.34
0.44
1.3
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
110
1208
0.91
0.44
1.7
2.1
g/l
125.4
126.9
0.27
69
842
(3015235) Bicarbonate [Moles/volume] in Capillary blood
106
1166
0.91
0.43
2.5
2.9
mmol/l
25.7
25.3
0.48
90
1023
(3044242) Glucose [Moles/volume] in Arterial blood
19
241
0.79
0.43
1.3
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
46
396
1.16
0.42
1.6
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
112
1226
0.91
0.42
1.3
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
273
0.81
0.42
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
111
1215
0.91
0.42
1.3
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
76
848
0.89
0.41
1.1
1.1
u/ml
0.5
1.0
1.19
28
314
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
305
0.82
0.41
1.1
1.1
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.6
—
0
10
(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid
0
15
0.00
0.41
0.0
5.1
—
1.7
—
0
15
(3022217) INR in Platelet poor plasma by Coagulation assay
677
7000
0.96
0.41
15.2
22.3
inr
1.2
1.3
0.27
78
1008
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
12097.4
—
0
5
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
8
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
453
4722
0.96
0.41
3.0
4.1
%
0.4
0.2
2.69
179
1181
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3017958) Strawberry IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
0.0
—
0
7
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
27
223
1.21
0.39
2.0
2.1
ug/min
11.6
109.4
—
5
40
(3000492) Spirometry study
525
5449
0.96
0.39
1.4
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
215
2023
1.06
0.39
1.9
2.3
g/l
3.2
3.1
1.04
170
1545
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
27
324
0.83
0.39
1.1
1.1
—
—
—
0
0
(4268621)
51
580
0.88
0.38
2.2
2.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
17
133
1.28
0.38
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
18
142
1.27
0.38
1.1
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
18
142
1.27
0.38
1.2
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
66
1.36
0.38
1.9
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
348
3642
0.95
0.38
1.8
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
79
713
1.11
0.38
1.4
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
175
1868
0.94
0.37
2.3
3.5
mmol/l
25.4
25.2
0.51
155
1700
(3023511) Choriogonadotropin [Units/volume] in Urine
67
747
0.90
0.37
2.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
306
3211
0.95
0.37
5.2
6.7
mmol/l
25.0
24.9
0.21
288
2980
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3664
36984
0.98
0.37
2.8
2.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
84
762
1.10
0.37
1.3
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
9
69
1.30
0.37
1.0
1.1
—
—
—
0
0
(4133840)
8
115
0.70
0.37
1.3
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
56
630
0.89
0.36
1.9
2.2
mmol/l
4.0
4.0
0.01
56
625
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
9
70
1.29
0.36
1.2
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
27
321
0.84
0.36
2.3
2.0
u/field
2.6
1.9
0.30
19
226
(3035285) Chloride [Moles/volume] in Venous blood
56
629
0.89
0.36
1.9
2.2
mmol/l
104.0
105.6
1.60
56
624
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
129
1389
0.93
0.35
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
73
659
1.11
0.35
1.4
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
200
2120
0.94
0.35
2.3
3.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
42
1.43
0.35
1.2
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
125
0.72
0.35
1.1
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
21
255
0.82
0.35
1.3
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
44
1.36
0.34
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
132
1416
0.93
0.34
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
759
7385
1.03
0.34
2.2
2.4
%
22.4
21.7
0.67
685
6253
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
77
700
1.10
0.33
1.2
1.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
6
90
0.67
0.32
1.0
1.1
—
0.1
—
0
15
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
27
317
0.85
0.32
1.7
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
231
2196
1.05
0.32
1.6
1.7
mg/l
2.3
3.4
2.20
177
1593
(3033705) Calcium.ionized [Moles/volume] in Venous blood
56
623
0.90
0.32
1.9
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
39
444
0.88
0.32
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
47
528
0.89
0.31
1.7
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
678
6963
0.97
0.31
3.5
4.8
mmol/l
1.0
1.0
1.51
619
6411
(3047007) Chlamydophila sp Ab [Presence] in Serum
82
892
0.92
0.30
1.3
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
54
1.30
0.30
2.7
2.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
75
1.33
0.30
1.1
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
7
56
1.25
0.29
3.6
2.9
umol/l
33.7
39.9
—
7
46
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
26
222
1.17
0.29
1.2
1.1
ng/l
54.7
834.6
—
7
46
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
91
982
0.93
0.29
1.1
1.1
u/ml
1.3
1.0
0.16
32
335
(3020717) Zinc [Moles/volume] in Serum or Plasma
30
345
0.87
0.29
1.5
1.4
umol/l
39.0
25.4
1.20
30
328
(3016018) Differential panel - Cerebral spinal fluid
56
618
0.91
0.28
1.1
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
34
387
0.88
0.28
1.2
1.3
—
480.4
—
0
28
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
24
204
1.18
0.28
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
65
593
1.10
0.28
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
27
312
0.86
0.28
1.6
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
26
301
0.86
0.27
1.5
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
15
183
0.82
0.27
1.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
13
161
0.81
0.27
2.1
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
88
817
1.08
0.26
1.1
1.1
%
123.1
122.4
0.10
83
735
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
154
1625
0.95
0.26
1.1
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
208
1987
1.05
0.26
2.0
2.3
g/l
9.9
10.1
0.41
174
1646
(40758292) HTLV I+II Ab panel - Serum
5
75
0.67
0.25
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
41
367
1.12
0.25
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
86
800
1.08
0.25
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
85
791
1.08
0.25
1.3
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
12
96
1.25
0.24
1.3
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
276
2660
1.04
0.24
6.4
8.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
50
455
1.10
0.24
3.4
1.7
nmol/l
11.2
6.3
2.12
41
371
(3025468) Yersinia sp identified in Specimen by Organism specific culture
85
793
1.07
0.24
1.3
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
85
0.71
0.24
13.3
8.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
85
794
1.07
0.23
1.3
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
13
106
1.23
0.23
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
485
4974
0.97
0.22
1.3
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
383
3721
1.03
0.22
2.5
2.9
kpa
4.6
4.5
0.10
362
3601
(3021162) Amylase [Enzymatic activity/volume] in Specimen
7
94
0.74
0.22
2.6
3.0
u/l
405.9
3674.5
—
7
87
(3051101) Glucose [Moles/volume] in Cord blood
7
95
0.74
0.22
7.0
5.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
85
796
1.07
0.22
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1299
13170
0.98
0.22
3.7
4.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
61
659
0.92
0.22
1.0
1.1
u/ml
1.5
2.4
0.70
21
231
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
18
210
0.86
0.22
1.3
1.3
—
—
—
0
0
(3025315) Body weight
5
41
1.22
0.22
5.2
4.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
53
576
0.92
0.22
1.1
1.1
u/ml
0.0
0.5
—
9
110
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
27
305
0.88
0.22
1.1
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
93
988
0.94
0.21
2.1
2.7
kpa
8.2
8.2
0.03
83
920
(3004716) Salmonella sp identified in Stool by Organism specific culture
308
3177
0.97
0.21
1.4
1.4
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
5.2
—
0.2
—
0
10
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
11
0.00
0.21
0.0
1.2
—
4.3
—
0
11
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
122.3
—
0
11
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
94
885
1.06
0.21
1.0
1.1
u/ml
1.8
3.6
1.58
43
401
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
135
1.19
0.21
1.1
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055459) Dabigatran [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
134.5
—
0
6
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
104
0.77
0.21
1.0
1.1
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
5
43
1.16
0.21
2.8
1.6
%
21.6
14.3
—
5
30
(3006969) Lambda light chains [Mass/volume] in Urine
0
13
0.00
0.21
0.0
1.0
—
0.0
—
0
6
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3027874) Urate [Moles/volume] in Urine
0
13
0.00
0.21
0.0
1.0
—
1.5
—
0
8
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
13
0.00
0.21
0.0
6.2
—
361.8
—
0
13
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
22
192
1.15
0.20
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
53
489
1.08
0.20
2.1
2.9
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(3009883) Potato IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.0
—
0
9
(40768446) Kidney Pathology biopsy report
13
155
0.84
0.20
1.5
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
37
407
0.91
0.20
1.3
1.3
mmol/l
11.6
11.5
—
8
97
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
49
1.22
0.20
2.2
1.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
138
1444
0.95
0.20
2.5
2.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
811
7973
1.02
0.19
2.0
2.3
g/l
2.4
2.4
0.19
757
7356
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
51
1.18
0.19
1.2
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
17
146
1.16
0.19
1.2
2.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
122
1278
0.95
0.19
3.2
2.8
mg/l
1.2
1.5
5.49
110
1177
(44813793)
42
457
0.92
0.18
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
205
2122
0.96
0.18
1.6
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
18
156
1.15
0.18
1.3
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
66
703
0.94
0.18
1.0
1.1
u/ml
2.6
3.0
0.11
18
232
(3021447) Carbon dioxide [Partial pressure] in Venous blood
461
4511
1.02
0.18
2.8
3.5
kpa
5.9
5.8
0.29
439
4386
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
86
814
1.06
0.17
1.3
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
459
4493
1.02
0.17
2.9
3.5
mmol/l
2.4
2.1
0.96
376
3716
(44806420)
12
142
0.84
0.17
1.5
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
62
581
1.07
0.17
2.0
3.7
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
62
1.13
0.17
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
20
226
0.88
0.17
1.3
2.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
50
537
0.93
0.17
2.0
3.1
%
56.9
57.0
0.01
28
354
(3017732) Neutrophils [#/volume] in Blood
425
4342
0.98
0.17
3.6
2.8
e9/l
3.8
4.0
0.44
359
3355
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
67
0.75
0.17
1.0
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
17
148
1.15
0.16
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
120
1150
1.04
0.16
2.7
3.4
mmol/l
2.4
2.7
0.56
90
829
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
172
0.87
0.15
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
130
1.15
0.15
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
79
0.76
0.15
1.2
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
119
0.84
0.15
1.1
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
119
0.84
0.15
1.0
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
96
917
1.05
0.15
1.4
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
220
2138
1.03
0.15
1.9
2.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
103
1075
0.96
0.15
2.5
3.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
16
140
1.14
0.15
1.1
1.1
—
—
—
0
0
(3036603) Volume of Urine
39
420
0.93
0.15
1.4
1.5
ml
2423.1
1959.5
—
8
95
(3025018) Bordetella pertussis Ab [Titer] in Serum
36
389
0.92
0.14
1.3
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
88
0.80
0.14
1.0
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
220
2142
1.03
0.14
1.9
2.3
g/l
7.5
7.5
0.01
176
1588
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
16
141
1.13
0.13
1.1
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
8
98
0.82
0.13
1.0
1.1
mg/g
5.4
6.2
—
8
91
(3043409) Potassium [Moles/volume] in Arterial blood
165
1600
1.03
0.13
3.0
3.9
mmol/l
3.7
3.8
1.34
159
1515
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
128
0.86
0.13
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
35
376
0.93
0.13
1.0
1.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
23
252
0.91
0.12
1.7
1.5
pmol/l
14.8
15.3
0.28
18
209
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
142
1.13
0.12
1.2
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
24
262
0.92
0.12
1.6
2.2
ug/l
19.0
149.9
0.67
24
247
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
42
447
0.94
0.12
1.3
1.5
u/ml
19.6
21.2
—
7
93
(3025941) Bacteria identified in Stool by Culture
345
3514
0.98
0.12
1.3
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
219
2138
1.02
0.12
1.9
2.3
g/l
3.7
3.7
0.02
165
1502
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1034
10435
0.99
0.11
1.4
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
105
1087
0.97
0.11
1.4
1.4
mmol/l
54.7
62.0
1.17
76
869
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
95
1.16
0.11
1.0
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
572
5644
1.01
0.11
2.0
2.4
%
1.9
1.8
1.08
510
4986
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
18
199
0.90
0.11
2.1
2.2
umol/l
36.7
54.5
2.90
13
156
(4094501)
148
1521
0.97
0.11
1.1
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
10
86
1.16
0.11
1.9
1.7
pmol/l
65.3
61.3
—
10
73
(40765096) Chromosome analysis panel by Banding
15
134
1.12
0.10
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
26
280
0.93
0.10
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
26
280
0.93
0.10
1.2
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
16
144
1.11
0.10
1.4
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
413
4070
1.02
0.10
4.8
6.6
mmol/l
7.9
9.1
2.79
391
3876
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
574
5671
1.01
0.10
3.1
4.1
u/l
271.5
245.3
1.20
548
5311
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
51
486
1.05
0.10
1.2
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
44
1.14
0.10
3.4
2.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
6087
60932
0.99
0.09
15.2
12.6
—
—
—
0
0
(3020891) Body temperature
206
2102
0.98
0.09
3.5
4.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
47
1.06
0.09
7.4
6.9
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
5
47
1.06
0.09
2.6
1.6
%
30.6
39.5
—
5
31
(46235168) Fasting glucose [Moles/volume] in Blood
5
48
1.04
0.09
2.2
1.4
mmol/l
8.3
7.3
—
5
24
(3003721) Smooth muscle Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.2
—
1.2
—
0
7
(4306422)
82
848
0.97
0.09
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
194
1.08
0.09
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
66
1.06
0.08
1.0
1.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
84
865
0.97
0.08
1.2
1.2
u/ml
1.6
2.9
1.76
25
262
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
73
0.82
0.07
3.5
2.7
u/field
0.2
0.8
—
6
73
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
74
1.08
0.07
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
147
1.09
0.07
1.5
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
80
0.87
0.07
1.1
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
93
0.86
0.06
2.3
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1424
14177
1.01
0.06
3.2
4.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
11
121
0.91
0.06
1.4
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
131
0.92
0.05
1.3
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
42
405
1.04
0.05
1.3
2.1
%
10.1
10.8
0.57
42
405
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
21
222
0.95
0.05
2.2
2.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
29
303
0.96
0.05
1.1
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
872
8758
0.99
0.04
2.1
2.3
umol/l
13.4
12.9
1.10
814
8062
(3010726) Horse dander IgE Ab [Units/volume] in Serum
77
786
0.98
0.04
1.1
1.1
u/ml
1.3
1.5
0.10
16
168
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
234
2317
1.01
0.04
2.3
2.7
%
0.6
0.7
0.63
223
2225
(3036071) Salmonella sp Ab [Titer] in Serum
16
170
0.94
0.04
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
28
290
0.97
0.03
3.5
3.8
—
—
—
0
0
(4211845)
32
310
1.03
0.03
3.2
3.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
14
132
1.06
0.02
1.8
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
85
861
0.99
0.02
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
95
939
1.01
0.02
1.1
1.1
au/ml
5.0
13.0
—
6
35
(3016038) Potassium [Moles/volume] in Urine
40
391
1.02
0.02
1.3
1.1
mmol/l
34.0
33.5
0.04
35
328
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
44
431
1.02
0.02
1.1
1.1
iu/ml
8.3
10.1
0.22
14
105
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
11
103
1.07
0.02
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
117
0.94
0.01
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
37
378
0.98
0.01
1.3
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
107
1079
0.99
0.01
2.0
2.4
%
16.0
16.1
0.13
48
533
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
236
2370
1.00
0.01
2.3
2.8
%
1.1
1.2
2.80
236
2357
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
13
136
0.96
0.00
1.3
1.3
ng/l
87.1
88.5
0.05
13
136
(3006270) Folate [Moles/volume] in Blood
53
524
1.01
0.00
1.2
1.1
nmol/l
361.7
369.7
0.10
46
458
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
505
5043
1.00
0.00
1.7
1.7
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
14
137
1.02
0.00
1.1
1.1
umol/24h
0.4
0.7
—
6
61
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
30
297
1.01
0.00
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
37
369
1.00
0.00
1.3
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
141
0.99
0.00
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
265
0.98
0.00
1.2
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
12
123
0.98
0.00
2.5
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
343
3424
1.00
0.00
1.4
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
493
4927
1.00
0.00
2.9
4.0
%
1.9
0.9
5.59
197
1280
(3051593) INR in Capillary blood by Coagulation assay
23
230
1.00
0.00
11.6
11.6
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
15
146
1.03
0.00
1.6
1.4
%
47.3
37.8
—
9
100
(3002719) Hemoglobin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
70
1.00
0.00
1.0
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
62
0.97
0.00
1.2
1.2
umol/24h
1.8
1.6
—
6
62
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
9
97
0.93
0.00
2.0
1.7
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
49
1.02
0.00
2.0
1.9
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
8.1
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
5
0.00
0.00
0.0
2.6
—
5.8
—
0
5
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
298.4
—
0
5
(3036005) Urine sediment comments by Light microscopy Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.2
—
0
6
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
85
0.94
0.00
1.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
58
0.86
0.00
1.2
1.2
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
49
1.02
0.00
4.4
4.9
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
78
0.90
0.00
3.3
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
80
1.00
0.00
1.1
2.0
—
—
—
0
0
(3045759) Histamine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
85
0.94
0.00
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
85
0.94
0.00
1.0
1.0
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
53
0.94
0.00
1.8
1.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
73
0.96
0.00
1.1
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L02BA – L02BA Anti-estrogens
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).